Name | Price | Volume | Analyst Price Target | Analyst Consensus | Smart Score | Market Cap | P/E Ratio | Dividend Yield | Sector | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $125.00 | 5.31M | xxxxxxxxxxxxx | 16 Buy 3 Hold 0 Sell Strong Buy | $153.73B | 19.19 | 2.53% | Healthcare | ||||
| $345.42 | 2.84M | xxxxxxxxxxxxx | 8 Buy 10 Hold 1 Sell Moderate Buy | $182.20B | 26.16 | 2.81% | Healthcare | ||||
| $463.13 | 2.54M | xxxxxxxxxxxxx | 15 Buy 6 Hold 0 Sell Moderate Buy | $109.90B | 30.53 | ― | Healthcare | ||||
| $180.75 | 1.85M | xxxxxxxxxxxxx | 12 Buy 10 Hold 0 Sell Moderate Buy | $26.43B | 16.43 | ― | Healthcare | ||||
| $127.95 | 831.63K | xxxxxxxxxxxxx | 4 Buy 5 Hold 3 Sell Hold | $19.49B | 28.58 | ― | Healthcare | ||||
| $723.67 | 1.24M | xxxxxxxxxxxxx | 16 Buy 6 Hold 1 Sell Moderate Buy | $77.98B | 17.76 | 0.47% | Healthcare | ||||
| $25.18 | 7.78M | xxxxxxxxxxxxx | 3 Buy 12 Hold 4 Sell Hold | $9.40B | ― | ― | Healthcare | ||||
| $227.24 | 1.23M | xxxxxxxxxxxxx | 14 Buy 3 Hold 0 Sell Strong Buy | $38.42B | 30.98 | ― | Healthcare | ||||
| $96.73 | 3.48M | xxxxxxxxxxxxx | 13 Buy 3 Hold 0 Sell Strong Buy | $23.11B | ― | ― | Healthcare |
Stock | Type | Date |
|---|---|---|
Gilead Sciences | Ex-Dividend Date | Dec 15, 2025 |
Biogen | Earnings Release | Jan 29, 2026 |
Regeneron | Earnings Release | Jan 30, 2026 |
Amgen | Earnings Release | Feb 03, 2026 |
Vertex Pharmaceuticals | Earnings Release | Feb 04, 2026 |